Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

February 01, 2020; Volume 372,Issue 2

Cardiovascular

  • You have access
    Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins
    Maria V. Fawaz, Sang Yeop Kim, Dan Li, Ran Ming, Ziyun Xia, Karl Olsen, Irina D. Pogozheva, John J.G. Tesmer and Anna Schwendeman
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 193-204; DOI: https://doi.org/10.1124/jpet.119.257568

Cellular and Molecular

  • M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body <em>β</em>-Hydroxybutyrate
    You have access
    M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate
    Rían W. Manville, Maria Papanikolaou and Geoffrey W. Abbott
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 148-156; DOI: https://doi.org/10.1124/jpet.119.263350

Drug Discovery and Translational Medicine

  • You have access
    OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention
    David R. Maguire, Lisa R. Gerak, Gerta Cami-Kobeci, Stephen M. Husbands, Charles P. France, Barbara Belli and Peter Flynn
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 205-215; DOI: https://doi.org/10.1124/jpet.119.261511
  • You have access
    5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury
    Epiphani C. Simmons, Natalie E. Scholpa, Kristan H. Cleveland and Rick G. Schnellmann
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 216-223; DOI: https://doi.org/10.1124/jpet.119.262410
  • Open Access
    A Novel G Protein–Biased Agonist at the δ Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain
    Alexandra E. Conibear, Junaid Asghar, Rob Hill, Graeme Henderson, Eva Borbely, Valeria Tekus, Zsuzsanna Helyes, Josephine Palandri, Chris Bailey, Ingemar Starke, Bengt von Mentzer, David Kendall and Eamonn Kelly
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 224-236; DOI: https://doi.org/10.1124/jpet.119.258640

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats
    Sota Kato, Teisuke Takahashi, Noriyuki Miyata and Richard J. Roman
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 166-174; DOI: https://doi.org/10.1124/jpet.119.262782

Inflammation, Immunopharmacology, and Asthma

  • You have access
    EP2/4 Receptors Promote the Synthesis of PGE2 Increasing Tissue Damage in Bovine Endometrial Explants Induced by Escherichia coli
    Chao Zhang, Lingrui Wang, Tingting Li, Wei Mao, Bo Liu and Jinshan Cao
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 175-184; DOI: https://doi.org/10.1124/jpet.119.262444
  • All-Trans Retinoic Acid Inhibits Migration and Invasiveness of Rheumatoid Fibroblast-Like Synoviocytes
    Open Access
    All-Trans Retinoic Acid Inhibits Migration and Invasiveness of Rheumatoid Fibroblast-Like Synoviocytes
    Nerea Mosquera, Angela Rodriguez-Trillo, Francisco J. Blanco, Antonio Mera-Varela, Antonio Gonzalez and Carmen Conde
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 185-192; DOI: https://doi.org/10.1124/jpet.119.261370

Toxicology

  • 3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing <em>α</em>-Synuclein
    You have access
    3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein
    Yunden Jinsmaa, Risa Isonaka, Yehonatan Sharabi and David S. Goldstein
    Journal of Pharmacology and Experimental Therapeutics February 2020, 372 (2) 157-165; DOI: https://doi.org/10.1124/jpet.119.262246
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 372 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 372, Issue 2
1 Feb 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Cardiovascular
  • Cellular and Molecular
  • Drug Discovery and Translational Medicine
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Toxicology
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics